Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
heart disease
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
2
×
san francisco top stories
sanofi
seattle blog main
seattle top stories
study
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acc
acquisition
activist investor
aducanumab
alirocumab
alzheimer's failure
american college of cardiology
amgen
amyloid
andreas grauer
What
drug
2
×
adu
approved
beats
bids
bio
biogen
cholesterol
complicated
depression
dire
drugs
expensive
faces
financial
foe
good
group
healthcare
heart
help
hint
inhibitors
known
lowering
medical
need
new
news
pcsk
people
postpartum
relief
remember
roundup
sage
supposed
tough
wave
week
Language
unset
Current search:
study
×
drug
×
" san francisco blog main "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More